Literature DB >> 15541256

Temporal repolarization lability differences among genotyped patients with the long QT syndrome.

Kenneth Bilchick1, Matti Viitasalo, Lasse Oikarinen, Barry Fetics, Gordon Tomaselli, Heikki Swan, Päivi J Laitinen, Heikki Väänänen, Kimmo Kontula, Ronald D Berger.   

Abstract

The investigators sought to test whether certain long QT syndrome (LQTS) mutations are associated with increased repolarization lability and whether repolarization lability (quantified by the QT variability index [QTVI]) is increased in patients with LQTS compared with controls. In 32 genotyped patients with LQTS type 1 (LQT1), 32 genotyped patients with LQTS type 2 (LQT2), and 32 controls, the QTVI was increased in patients with LQT2 (-0.973 +/- 0.394, p = 0.01 vs controls) and in patients with LQT1 with mutations other than KCNQ1-FIN (-0.942 +/- 0.264, p = 0.04 vs controls) but was similar between the KCNQ1-FIN group and controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541256     DOI: 10.1016/j.amjcard.2004.07.123

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Single photon emission computed tomography (SPECT) techniques for resynchronization: phase analysis and equilibrium radionuclide angiocardiography.

Authors:  Kenneth C Bilchick
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Slow QT interval adaptation to heart rate changes in normal ambulatory subjects.

Authors:  Eathar Razak; Marie Buncová; Vladimir Shusterman; Bruce Winter; Win-Kuang Shen; Michael J Ackerman; Theresa Donovan; Rachel Lampert; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

3.  Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac death.

Authors:  Larisa G Tereshchenko; Iwona Cygankiewicz; Scott McNitt; Rafael Vazquez; Antoni Bayes-Genis; Lichy Han; Sanjoli Sur; Jean-Philippe Couderc; Ronald D Berger; Antoni Bayes de Luna; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-23

Review 4.  Towards a better understanding of QT interval variability.

Authors:  Larisa G Tereshchenko; Ronald D Berger
Journal:  Ther Adv Drug Saf       Date:  2011-12

5.  Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.

Authors:  Claus Graff; Johannes J Struijk; Jørgen K Kanters; Mads P Andersen; Egon Toft; Benoît Tyl
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

6.  Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes.

Authors:  Elke Detre; Morten B Thomsen; Jet D Beekman; Karl-Uwe Petersen; Marc A Vos
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

7.  Autonomic and Cardiac Repolarization Lability in Long QT Syndrome Patients.

Authors:  Natalia DeMaria; Ahmed Selmi; Samuel Kashtan; Xiaojuan Xia; Matthew Wang; Wojciech Zareba; Jean-Philippe Couderc; David S Auerbach
Journal:  Auton Neurosci       Date:  2020-09-06       Impact factor: 3.145

8.  Variability of Myocardial Repolarization in Pediatric Patients with a Ventricular Septal Defect.

Authors:  Hidetoshi Uchida; Miki Nishio; Yumi Omeki; Yuka Takeuchi; Rina Nagata; Shota Oikawa; Arisa Nagatani; Yoshihiko Eryu; Tadayoshi Hata; Tetsushi Yoshikawa
Journal:  Pediatr Cardiol       Date:  2016-08-23       Impact factor: 1.655

Review 9.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

10.  HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS).

Authors:  Amir S Heravi; Lacey H Etzkorn; Jacek K Urbanek; Ciprian M Crainiceanu; Naresh M Punjabi; Hiroshi Ashikaga; Todd T Brown; Matthew J Budoff; Gypsyamber D'Souza; Jared W Magnani; Frank J Palella; Ronald D Berger; Katherine C Wu; Wendy S Post
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.